Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human Remove Human filter Veterinary Remove Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter Shortages Remove Shortages filter

Date of opinion

From:

To:

Referral name

Referral status

European Commission final decision (153) Apply European Commission final decision filter CMDh final position (3) Apply CMDh final position filter

Referral safety status

Yes (10) Apply Yes filter

Referral type

Article 29(4) referrals Remove Article 29(4) referrals filter Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter Article 107i procedures Remove Article 107i procedures filter Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter Article 31 referrals (122) Apply Article 31 referrals filter Article 30 referrals (95) Apply Article 30 referrals filter Article 35 (45) Apply Article 35 filter Article 33 (43) Apply Article 33 filter Article 20 procedures (26) Apply Article 20 procedures filter Article 34 (20) Apply Article 34 filter Article 107 procedures (prior to July 2012) (15) Apply Article 107 procedures (prior to July 2012) filter Article 29 paediatrics (9) Apply Article 29 paediatrics filter Article 36 referrals (prior to July 2012) (9) Apply Article 36 referrals (prior to July 2012) filter Article 13 (6) Apply Article 13 filter Article 13 referrals (6) Apply Article 13 referrals filter Article 78 (5) Apply Article 78 filter Articles 39 and 40 (4) Apply Articles 39 and 40 filter Article 5(11) referrals (prior to January 2010) (2) Apply Article 5(11) referrals (prior to January 2010) filter Article 82 (2) Apply Article 82 filter

Referral reference number

Referral decision making model

PRAC-CMDh (9) Apply PRAC-CMDh filter

Referral authorisation model

Nationally authorised product(s) (23) Apply Nationally authorised product(s) filter

Referral PRAC recommendation

Revocation (1) Apply Revocation filter Risk minimisation measures (4) Apply Risk minimisation measures filter Suspension (3) Apply Suspension filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Decision date

From:

To:

Related medicine

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

156 results

Remove all filtersRemove all filters

Medicine Shortages Remove Shortages filter European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Referrals Remove Referrals filter

Referral type Article 6(12) referrals (prior to January 2010) Remove Article 6(12) referrals (prior to January 2010) filter Article 29(4) referrals Remove Article 29(4) referrals filter Article 6(13) referrals (prior to January 2010) Remove Article 6(13) referrals (prior to January 2010) filter Article 107i procedures Remove Article 107i procedures filter

Categories Veterinary Remove Veterinary filter Human Remove Human filter

Sort by

List item

Referral: Methadone medicinal products for oral use containing povidone

methadone, Article 107i procedures
Status: CMDh final position, opinion/position date: 23/07/2014, Last updated: 04/08/2014
List item

Referral: Nanotop and associated names

human albumin, denatured, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 28/02/2014, Last updated: 16/06/2014
List item

Referral: Tibolona Aristo and Tibocina and associated names

tibolone, associated names: Tibolon Aristo, Tibolinia, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 05/03/2014, Last updated: 08/04/2014
List item

Referral: Valebo and associated names

alendronic acid, alfacalcidol, associated names: Tevabone, Teboneva, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/12/2013, EC decision date: 10/03/2014, Last updated: 31/03/2014
List item

Referral: Hydroxyethyl starch solutions for infusion

hydroxyethyl starch, Article 107i procedures
Status: European Commission final decision, opinion/position date: 23/10/2013, EC decision date: 19/12/2013, Last updated: 06/03/2014
List item

Referral: Okrido

prednisolone sodium phosphate, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 27/06/2013, EC decision date: 05/09/2013, Last updated: 03/01/2014
List item

Referral: Didanosine

didanosine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/09/2013, EC decision date: 20/11/2013, Last updated: 10/12/2013
List item

Referral: Methylphenidate Sandoz

methylphenidate hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2013, EC decision date: 09/10/2013, Last updated: 05/12/2013
List item

Referral: Methylphenidate Hexal

methylphenidate hydrochloride, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/07/2013, EC decision date: 09/10/2013, Last updated: 05/12/2013
List item

Referral: Flupirtine-containing medicines

flupirtine, Article 107i procedures
Status: European Commission final decision, opinion/position date: 26/06/2013, EC decision date: 05/09/2013, Last updated: 21/11/2013
List item

Referral: Ciclosporin IDL

ciclosporin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/03/2010, EC decision date: 22/07/2010, Last updated: 20/11/2013
List item

Referral: Avalox

moxifloxacin, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/06/2009, EC decision date: 02/10/2009, Last updated: 19/11/2013
List item

Referral: Numeta G13%E and Numeta G16%E emulsion for infusion

Article 107i procedures
Status: CMDh final position, opinion/position date: 18/09/2013, Last updated: 27/09/2013
List item

Referral: Cyproterone- and ethinylestradiol-containing medicines

cyproterone, ethinyl estradiol, associated names: Acnemine, Acneson, Chloe, Clairette, Cyprest, Cyprodiol, Diane 35, Dianette, Feminil, Minerva, Zyrona, Article 107i procedures
Status: European Commission final decision, opinion/position date: 29/05/2013, EC decision date: 25/07/2013, Last updated: 05/08/2013
List item

Referral: Furosemide Vitabalans

furosemide, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/02/2013, EC decision date: 14/05/2013, Last updated: 30/07/2013
List item

Referral: Simvastatin Vale

simvastatin, associated names: Simvastatin Vale pharmaceuticals, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 25/03/2013, EC decision date: 27/05/2013, Last updated: 22/07/2013
List item

Referral: Tetrazepam-containing medicines

tetrazepam, associated names: Myolastan and generics, Article 107i procedures
Status: European Commission final decision, opinion/position date: 24/04/2013, EC decision date: 29/05/2013, Last updated: 18/07/2013
List item

Referral: Loraxin

loratadine, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 18/10/2012, EC decision date: 20/12/2012, Last updated: 28/02/2013
List item

Referral: Mometasone Furoate Sandoz

mometasone furoate, associated names: Mometasone Sandoz, Mometasone Sandoz 50, Mometasone Furoato Sandoz 50, Mommox, Nasometi, Fumomo 50, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 08/10/2012, Last updated: 24/01/2013
List item

Referral: Ethinylestradiol-Drospirenone 24+4

ethinyl estradiol, drospirenone, associated names: Yaz 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 06/07/2012, Last updated: 11/01/2013
List item

Referral: Yaz 24+4

ethinylestradiol, drospirenone, associated names: Ethinylestradiol-Drospirenone 24+4, Article 6(12) referrals (prior to January 2010)
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 03/07/2012, Last updated: 11/01/2013
List item

Referral: Mifepristone Linepharma

mifepristone, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 21/06/2012, EC decision date: 11/09/2012, Last updated: 03/01/2013
List item

Referral: Yvidually

ethinylestradiol, drospirenone, associated names: Flexyess, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 28/09/2012, Last updated: 03/01/2013
List item

Referral: Glimepirida Parke-Davis

glimepiride, associated names: Glimepiride Pfizer, Glimepirid Pfizer, Glimepiride tablets 2 mg, Glimepiride tablets 3 mg, Glimepiride tablets 4 mg, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/07/2012, EC decision date: 19/11/2012, Last updated: 06/12/2012
List item

Referral: Iffeza

fluticasone propionate, formoterol fumarate, associated names: Flutiform, Flofera, Flutiformo, Article 29(4) referrals
Status: European Commission final decision, opinion/position date: 19/04/2012, EC decision date: 28/06/2012, Last updated: 25/10/2012

Load more

156 results

Referral: Methadone medicinal products for oral use containing povidone

Referral: Nanotop and associated names

Referral: Tibolona Aristo and Tibocina and associated names

Referral: Valebo and associated names

Referral: Hydroxyethyl starch solutions for infusion

Referral: Okrido

Referral: Didanosine

Referral: Methylphenidate Sandoz

Referral: Methylphenidate Hexal

Referral: Flupirtine-containing medicines

Referral: Ciclosporin IDL

Referral: Avalox

Referral: Numeta G13%E and Numeta G16%E emulsion for infusion

Referral: Cyproterone- and ethinylestradiol-containing medicines

Referral: Furosemide Vitabalans

Referral: Simvastatin Vale

Referral: Tetrazepam-containing medicines

Referral: Loraxin

Referral: Mometasone Furoate Sandoz

Referral: Ethinylestradiol-Drospirenone 24+4

Referral: Yaz 24+4

Referral: Mifepristone Linepharma

Referral: Yvidually

Referral: Glimepirida Parke-Davis

Referral: Iffeza